Carl R. Alving

13.7k citations
261 papers · 10.7k indexed · h-index 59
Topics
Immunotherapy and Immune Responses (62 papers)HIV Research and Treatment (57 papers)Monoclonal and Polyclonal Antibodies Research (54 papers)

In The Last Decade

Carl R. Alving

257 papers receiving 10.1k citations

Peers

Carl R. Alving
Comparison fields: 5 of 144
  • Immunology 4.4k
  • Molecular Biology 4.4k
  • Radiology, Nuclear Medicine and Imaging 1.4k
  • Epidemiology 1.4k
  • Infectious Diseases 1.3k
Replace Hansjörg Schild with:
Hansjörg Schild Germany
Magdalena Plebanski Australia
C. Russell Middaugh United States
Sylviane Muller France
Giampietro Corradin Switzerland
Martin F. Bachmann Switzerland
István Tóth Australia
James P. Tam United States
Harm HogenEsch United States
Manuel E. Patarroyo Colombia
Carl R. Alving relative to Hansjörg Schild Germany Hansjörg Schild's profile →
Citations per field
00.5×1.6×
Hansjörg Schild · 1×
Citations per year

Countries citing papers authored by Carl R. Alving

Since Specialization
Citations

This map shows the geographic impact of Carl R. Alving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl R. Alving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl R. Alving more than expected).

Fields of papers citing papers by Carl R. Alving

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl R. Alving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl R. Alving. The network helps show where Carl R. Alving may publish in the future.

Co-authorship network of co-authors of Carl R. Alving

This figure shows the co-authorship network connecting the top 25 collaborators of Carl R. Alving. A scholar is included among the top collaborators of Carl R. Alving based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl R. Alving. Carl R. Alving is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 38
3 43
4 16
5 6
6 4
7 59
8 51
9 59
10 14
11 38
12 14
13 53
14
Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation.
23
15 26
16 23
17 12
18 5
19 22
20
Metabolic fate of liposomal phosphatidylinositol in murine tumor cells: implications for the mechanism of tumor cell cytotoxicity.
12

About Carl R. Alving

Carl R. Alving is a scholar working on Virology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 261 papers that have together received 10.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (62 papers), HIV Research and Treatment (57 papers) and Monoclonal and Polyclonal Antibodies Research (54 papers). The work is most often cited by research in Virology (1.2k citations), Immunology (4.4k citations) and Pharmaceutical Science (748 citations). Carl R. Alving has collaborated with scholars based in United States, Israel and Switzerland. Frequent co-authors include Gary R. Matyas, Mangala Rao, Roberta L. Richards, Nabila M. Wassef, János Szebeni, Gregory M. Glenn, Zoltán Beck, Sándor Sávay, Kristina K. Peachman and Glenn M. Swartz. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026